4//SEC Filing
SAENGER BRADLEY 4
Accession 0001999371-24-002951
CIK 0001430306other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 5:07 PM ET
Size
8.0 KB
Accession
0001999371-24-002951
Insider Transaction Report
Form 4
SAENGER BRADLEY
Chief Financial Officer
Transactions
- Award
Stock Option
2024-02-27+282,000→ 282,000 totalExercise: $0.46From: 2025-02-27Exp: 2034-02-27→ Common Stock (282,000 underlying) - Award
Stock Option
2024-02-27+282,000→ 282,000 totalExercise: $0.37From: 2025-02-27Exp: 2034-02-27→ Common Stock (282,000 underlying)
Footnotes (2)
- [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
Documents
Issuer
Tonix Pharmaceuticals Holding Corp.
CIK 0001430306
Entity typeother
Related Parties
1- filerCIK 0001668150
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 5:07 PM ET
- Size
- 8.0 KB